Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Jacob Funds capitalized on Q4 market volatility and tech cooling by selectively adding high-conviction growth names like Snowflake in cloud/AI infrastructure, alongside cutting-edge biotech innovators Cabaletta Bio and Prime Medicine.
Full Quick Take
Jacob Funds capitalized on Q4 market volatility and tech cooling by selectively adding high-conviction growth names like Snowflake in cloud/AI infrastructure, alongside cutting-edge biotech innovators Cabaletta Bio and Prime Medicine.
The Artisan Global Discovery Fund logged modest absolute gains in Q3 but underperformed its benchmark due to tech software and financial sector headwinds.
Full Quick Take
The Artisan Global Discovery Fund logged modest absolute gains in Q3 but underperformed its benchmark due to tech software and financial sector headwinds.
Artisan Small Cap Fund lagged its benchmark in Q2 2025 due to a speculative rally in lower-quality stocks, but the managers leveraged market volatility to upgrade the portfolio with high-conviction secular growth names.
Full Quick Take
Artisan Small Cap Fund lagged its benchmark in Q2 2025 due to a speculative rally in lower-quality stocks, but the managers leveraged market volatility to upgrade the portfolio with high-conviction secular growth names.